Injeksi Toksin Botulinum pada Disfonia Spasmodik Tipe Adduktor

Wahyu Tri Novriansyah✉
DOI: https://doi.org/10.25077/mka.v45.i4.p686-694.2022

Abstract

Disfonia spasmodik adalah gangguan fonasi akibat gerakan involunter, intermiten dan ireguler dari otot-otot intrinsik laring. Hingga saat ini patofisiologinya masih belum jelas. Gejalanya yang tidak familiar di kalangan klinisi sering menyebabkan keterlambatan diagnosis. Terapi injeksi botulinum masih menjadi pilihan pertama untuk mengobati gejala disfonia spasmodik. Laporan Kasus: Seorang wanita 50 tahun mengeluh suara seperti tercekik dan terputus-putus saat bicara sejak 1,5 tahun lalu. Pemeriksaan laring tidak menemukan adanya lesi patologis. Diagnosis disfonia spasmodik tipe adduktor ditegakkan berdasarkan persepsi suara. Dilakukan injeksi botulinum pada otot tiroaritenoid, dan memberikan hasil yang memuaskan selama 3 bulan. Kesimpulan: Penegakkan diagnosis disfonia spasmodik masih merupakan tantangan untuk klinisi. Injeksi

Keywords

Disfonia spasmodik; injeksi botulinum; otot tiroaritenoid

Full Text:

PDF

References

Murry T. Spasmodic dysphonia: Let’s look at that again. J Voice [Internet]. 2014;28(6):694–9. Available from: http://dx.doi.org/10.1016/j.jvoice.2014.03.007

Hintze JM, Ludlow CL, Bansberg SF, Adler CH, Lott DG. Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors. Otolaryngol - Head Neck Surg (United States). 2017;157(4):551–7.

Hintze JM, Ludlow CL, Bansberg SF, Adler CH, Lott DG. Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology. Otolaryngol - Head Neck Surg (United States). 2017;157(4):558–64.

Hyodo M, Hisa Y, Nishizawa N, Omori K, Shiromoto O, Yumoto E, et al. The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan. Auris Nasus Larynx. 2021;48(2):179–84.

Nerurkar NK, Banu TP. Spasmodic dysphonia: A seven-year audit of dose titration and demographics in the indian population. J Laryngol Otol. 2014;128(7):649–53.

Mor N, Simonyan K, Blitzer A. Central Voice Production and Pathophysiology of Spasmodic Dysphonia. Laryngoscope. 2018;128(1):177–83.

LANGEVELD TNP. M, DROST HA, FRIJNS JHM. PERCEPTUAL CHARACTERISTICS OF ADDUCTOR SPASMODIC. Ann Otol Rhinol Laryng. 2000;109:741–8.

Pedrero-Escalas MF, García-López I, Santiago-Pérez S, Vivancos F, Gavilán J. Clinical Experience With Patients With Spasmodic Dysphonia and Primary Meige Syndrome. Acta Otorrinolaringol (English Ed [Internet]. 2019;70(1):1–5. Available from: https://doi.org/10.1016/j.otoeng.2018.10.003

Costello D, Rubin JS. Scott-Brown’s Otorhinolaryngology Head and Neck Surgery Eight Edition: Volume 3, Chapter 68: Movement Disorder of Larynx. Taylor and Francis CRC Press; 2019. p. 996–1001.

Ludlow CL, Domangue R, Sharma D, Jinnah HA, Perlmutter JS, Berke G, et al. Consensus-based attributes for identifying patients with spasmodic dysphonia and other voice disorders. JAMA Otolaryngol - Head Neck Surg. 2018;144(8):657–65.

Daraei P, Villari CR, Rubin AD, Hillel AT, Hapner ER, Klein AM, et al. The Role of Laryngoscopy in the Diagnosis of Spasmodic Dysphonia. 2014;140(3):228–32.

Peterson EA, Roy N, Awan SN, Merrill RM, Banks R, Tanner K. Toward validation of the cepstral spectral index of dysphonia (CSID) as an objective treatment outcomes measure. J Voice [Internet]. 2013;27(4):401–10. Available from: http://dx.doi.org/10.1016/j.jvoice.2013.04.002

Rees CJ, Blalock PD, Kemp SE, Halum SL, Koufman JA. Differentiation of adductor-type spasmodic dysphonia from muscle tension dysphonia by spectral analysis. Otolaryngol - Head Neck Surg. 2007;137(4):576–81.

Creighton FX, Hapner E, Klein A, Rosen A, Jinnah HA, Johns MM. Diagnostic Delays in Spasmodic Dysphonia: A Call for Clinician Education. J Voice. 2015;29(5):592–4.

Ludlow CL. Treatment for spasmodic dysphonia: Limitations of current approaches. Curr Opin Otolaryngol Head Neck Surg. 2009;17(3):160–5.

Casserly P, Timon C. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia. J Laryngol Otol. 2008;122(1):52–6.

Jeffcoat BT, Schweinfurth JM. Efficacy of a portable, audible-only electromyography device in the treatment of spasmodic dysphonia. Laryngoscope. 2008;118(5):942–3.

Weissbrod EPA, Francis DO. Neurologic and Neurodegenerative Diseases of the Larynx. Neurologic and Neurodegenerative Diseases of the Larynx. 2020.

Edelstein AJ, Miller RH. Treatment of spasmodic dysphonia. Vol. 264, Journal of the American Medical Association. 1990. p. 1319–22.

Blitzer A, Kirke DN. Neurologic Disorders of the Larynx Chapter 57 in CUMMINGS OTOLARYNGOLOGY–HEAD AND NECK SURGERY, SEVENTH EDITION. Elsevier; 2021. p. 57(832-834).

Blitzer A, Brin MF, Ramig LO. Neurologic Disorder of the Larynx Secod Edition. Thieme M. New York: Thieme Medical Publishers; 2009. Chapter 17 (160-196).

Matak I, Bölcskei K, Bach-rojecky L, Helyes Z. Mechanisms of Botulinum Toxin Type A Action on Pain. 2019;1–24.

Nakamura K, Muta H, Watanabe Y, Mochizuki R, Yoshida T, Suzuki M. Surgical treatment for adductor spasmodic dysphonia - Efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopy. Acta Otolaryngol. 2008;128(12):1348–53.

Tsuji DH, Chrispim FS, Imamura R, Sennes LU, Hachiya A. Impact in Vocal Quality in Partial Myectomy and Neurectomy Endoscopic of Thyroarytenoid Muscle in Patients with Adductor Spasmodic Dysphonia. Braz J Otorhinolaryngol [Internet]. 2006;72(2):261–6. Available from: http://dx.doi.org/10.1016/S1808-8694(15)30066-5

HS K, HS C, JY L, SE L. Radiofrequency-thyroarytenoid-myothermy-for-treatment-of-adductor-spasmodic-dysphonia-How-we-do-it_2008_Clinical-Otolaryngology.pdf. Clin Otolaryngol. 2008;33:607–28.

Sanuki T, Yumoto E. Long-term Evaluation of Type 2 Thyroplasty with Titanium Bridges for Adductor Spasmodic Dysphonia. Otolaryngol - Head Neck Surg (United States). 2017;157(1):80–4.



Bookmark and Share
-->